PF-8026

N/A

Report date: 2024/11/19 14:42:31
NME

Base Information

Drug NamePF-8026
Drug Alias NamePF-8026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnsysce Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsysce Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A